Found: 6
Select item for more details and to access through your institution.
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.764885
- By:
- Publication type:
- Article
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.
- Published in:
- Frontiers in Integrative Neuroscience, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00407
- By:
- Publication type:
- Article
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities.
- Published in:
- Molecules, 2021, v. 26, n. 23, p. 7236, doi. 10.3390/molecules26237236
- By:
- Publication type:
- Article
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00407
- By:
- Publication type:
- Article
G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors.
- Published in:
- Molecules, 2019, v. 24, n. 24, p. 4542, doi. 10.3390/molecules24244542
- By:
- Publication type:
- Article